Unknown

Dataset Information

0

RNA-seq of human cancer patient with BrafV600E mutant melanoma before and after treatment with PLX4032. EGA study

ABSTRACT: We have collected material from a patient who had BrafV600E mutant melanoma that was treated with PLX4032. We have germline DNA from the patient and DNA and RNA from distinct lesions before and after treatment with PLX4032. We have transcriptome sequenced these samples to obtain a snap shot of the mechanisms of resistance that are operative.

ORGANISM(S): Homo sapiens

SUBMITTER: The Wellcome Trust Sanger Institute 

PROVIDER: S-ECPF-ERAD-138 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown RNA-seq melanoma
| S-ECPF-GEOD-50535 | biostudies-other
Unknown KIT Suppresses BRAFV600E-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling.
| S-EPMC5679278 | biostudies-literature
Unknown Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
| S-EPMC5352202 | biostudies-literature
Unknown RNA-seq of human melanoma samples
| S-ECPF-ERAD-61 | biostudies-other
Unknown Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.
| S-EPMC5560871 | biostudies-literature
Unknown Oncogenic BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration [HT-seq]
| S-ECPF-GEOD-33092 | biostudies-other
Unknown Anticancer effects of combinational treatment with BRAFV600E siRNA and PI3K pathway inhibitors in melanoma cell lines harboring BRAFV600E.
| S-EPMC6006476 | biostudies-literature
Unknown Treatment of NRAS-mutant melanoma.
| S-EPMC4830486 | biostudies-literature
Unknown Breast Cancer RNA-seq
| S-ECPF-GEOD-58135 | biostudies-other
Unknown RNA-seq of human breast cancer cell lines. EGA study
| S-ECPF-ERAD-145 | biostudies-other